Skip to main content
letter
. 2022 Nov 1;67(5):605–609. doi: 10.1165/rcmb.2022-0181LE

Table 1.

Cytokine Assessment in BALF and Lung Tissue Lysate

Cytokine VCD/HDM VCD/Saline Vehicle/HDM Vehicle/Saline  
IgE (ng/mL + SEM) 597.1 ± 110.3 *(versus VCD/Sal) 36.3 ± 22.6 920 ± 236.20 ***(versus Veh/Sal) 5.2 ± 3.7 Serum
IL-4 (pg/mL + SEM) 65.1 ± 8.4 **(versus VCD/Sal) 32.8 ± 3.14 54.27 ± 6.3 *(versus Veh/Sal) 29.2 ± 3.7 BALFInline graphic
IL-5 (pg/mL + SEM) 194.1 ± 28.7 ****(versus VCD/Sal) 16.0 ± 3.9 134.1 ± 26.0 ***(versus Veh/Sal) 8.6 ± 3.0
IL-13 (pg/mL + SEM) 117.3 ± 16.2 83.0 ± 8.9 93.0 ± 14.5 74.9 ± 12.0
IL-4 (pg/mL + SEM) 23.62 ± 5.96 *(versus VCD/Sal) 4.45 ± 0.41 17.55 ± 7.73 3.35 ± 0.42 TissueInline graphic
IL-5 (pg/mL + SEM) 214.0 ± 54.78 116.4 ± 6.04 194.6 ± 74.36 120.1 ± 59.2
IL-13 (pg/mL + SEM) 155.0 ± 27.36 156.3 ± 19.11 153.0 ± 22.27 173.8 ± 19.16
IL-17A (pg/mL + SEM) 2962 ± 1479 146.5 ± 19.4 1963 ± 1076 125.7 ± 17.44
IL-17F (pg/mL + SEM) 1321 ± 94.99 *(versus Veh/Sal) 1360 ± 195.7 *(versus Veh/Sal) 1176 ± 275.5 457.5 ± 54.73
IL-22 (pg/mL + SEM) 162.9 ± 55.56 57.62 ± 8.66 106.0 ± 47.28 61.28 ± 15.67
IL-6 (pg/mL + SEM) 69.12 ± 4.86 *(versus Veh/HDM) 46.7 ± 2.59 53.2 ± 3.14 52.25 ± 5.09
KC (pg/mL + SEM) 136.9 ± 11.14 ***(versus Veh/HDM) 57.92 ± 3.14 86.61 ± 5.67 74.7 ± 9.29  

Cytokines were assessed in BAL fluid and lung lysates (tissue) by single or multiplex immunoassay kits; IgE was detected in serum by ELISA. Values shown are mean +/−SEM, n = minimum of 5 per group. Statistical analysis performed using one-way ANOVA for multiple comparisons.

*

P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001.